How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency?
The allopurinol test aims to distinguish carriers and noncarriers for ornithine transcarbamylase (OTC) deficiency. We have evaluated the reliability of the test in at-risk females of known genotype. Results based on urine orotidine and/or orotic acid measurement were compared in terms of sensitivity and specificity. Retrospectively, we analysed the results of allopurinol tests in 42 women (22 confirmed heterozygotes and 20 noncarriers) from 23 pedigrees at risk of being carriers for OTC deficiency. Using a cut-off of 2 standard deviations above the mean of controls, the highest sensitivity (91%) was given by orotidine alone or in combination with orotic acid, but specificity was only 70% and 65%, respectively. We conclude that the value of the allopurinol test for detecting OTC carriers in at-risk females is limited. This needs to be recognized when counselling families. The test still has a role as a safe, quick, noninvasive screen of individuals at risk, but test results in possible carriers should be interpreted with caution. In the absence of other supportive evidence, confirmation by mutation analysis is required.
Grünewald
S
S
Institute of Child Health, London, UK. stephanie.gruenewald@uni-essen.de
Fairbanks
L
L
Genet
S
S
Cranston
T
T
Hüsing
J
J
Leonard
J V
JV
Champion
M P
MP
D000328:Adult; D000493:Allopurinol / Q000652:urine*; D005260:Female; D006580:Genetic Carrier Screening / Q000379:methods*; D005838:Genotype; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D009954:Ornithine Carbamoyltransferase / Q000235:genetics*; D020163:Ornithine Carbamoyltransferase Deficiency Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics / Q000652:urine; D010375:Pedigree; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012307:Risk Factors
D000493:Allopurinol; D009954:Ornithine Carbamoyltransferase